Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection. Mayo-Munoz et al.

Name: Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection. Mayo-Munoz et al.
Creator: Peter Fineran
Published: 2022-10-10T19:32:03.237Z
Keywords: Microbiology

Fineran, Peter

doi:10.17632/h2j2k5fmgc.1

Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection. Mayo-Munoz et al.

Published: 10 October 2022| Version 1 | DOI: 10.17632/h2j2k5fmgc.1

Contributor:

Peter Fineran

Description

Exploring the role of type III-A CRISPR immunity and the accessory nuclease NucC during PCH45 jumbo phage infection

Files

Institutions

University of Otago

Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection. Mayo-Munoz et al.

Description

Files

Institutions

Categories

Licence